Le Lézard
Classified in: Health
Subjects: MAV, FVT

Media Invitation - Significant support to the McGill University Health Centre's (MUHC) Mental Health Mission


MONTRÉAL, Jan. 19, 2018 /CNW Telbec/ - The Montreal General Hospital Foundation invites representatives of the media to attend an important announcement regarding leading-edge mental health care at the Montreal General Hospital, on Monday, January 22, 2018 at 10 a.m., at 1650 Cedar Avenue.

 

Who:

Martine Alfonso, Interim President and General Director, McGill University Health Centre

Jean-Guy Gourdeau, President and CEO, Montreal General Hospital Foundation

Dr. Michaela Barbarosie, Director, Neuromodulation Unit, McGill University Health Centre



When:

Monday, January 22, 2018

10 a.m.                



Where:

Montreal General Hospital

Livingston Hall (L6-500)

1650 Cedar Avenue

Montréal, Québec, H3G 1A4

 

SOURCE Montreal General Hospital Foundation


These press releases may also interest you

at 15:12
The Canadian Life and Health Insurance Association (CLHIA) supports the steps announced by the Ontario government yesterday to help family doctors and other primary care providers spend more time with their patients and less time on paperwork. "Our...

at 15:05
On May 26, Dawnmarie Gaivin and Dana Johnson, founders of the Spellers Methodtm used by thousands of nonspeaking individuals with autism, in partnership with filmmaker Pat R. Notaro III, will launch a video-on-demand docuseries that chronicles what...

at 14:53
Erie Insurance (ERIE) has received the 2024 Best Employers: Excellence in Health & Well-being award from Business Group on Health. The annual corporate awards program recognizes companies across diverse sectors for advancing employee well-being...

at 14:41
Cartessa Aesthetics, a premier North American aesthetic medical device company, launches PHYSIQ 360, a groundbreaking technology that elevates non-invasive body contouring. PHYSIQ 360 is the next generation of the award-winning PHYSIQ body technology...

at 14:37
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScreen® 2.0, a comprehensive suite of assays that predict and evaluate potential risks of...

at 14:34
Arthritis is a crippling disease, affecting approximately one in four adults. It wreaks havoc on our joints by breaking down cartilage, the cushioning between bones. Once that cartilage deteriorates, there's no way to replace it. However, all this...



News published on and distributed by: